Clive Stubbs

Capecitabine compared with observation in resected biliary tract cancer (BILCAP): a randomised, controlled, multicentre, phase 3 study

Richard Fox, Daniel H. Palmer, Hassan Malik et al. · The Lancet Oncology · 2019 · 1.2K citations · Full text

Medicine, Oncology, Pharmacology +9

Sorafenib in combination with transarterial chemoembolisation in patients with unresectable hepatocellular carcinoma (TACE 2): a randomised placebo-controlled, double-blind, phase 3 trial

Tim Meyer, Richard Fox, Yuk Ting et al. · ˜The œLancet. Gastroenterology & hepatology · 2017 · 497 citations · Full text

Pharmacy, Oncology, Pharmacotherapy +11

Adjuvant capecitabine for biliary tract cancer: The BILCAP randomized study.

John Primrose, Richard Fox, Daniel H. Palmer et al. · Journal of Clinical Oncology · 2017 · 189 citations

Medicine, Oncology, Surgery +15

Gabapentin for chronic pelvic pain in women (GaPP2): a multicentre, randomised, double-blind, placebo-controlled trial

Andrew W. Horne, Katy Vincent, Catherine A Hewitt et al. · The Lancet · 2020 · 80 citations · Full text

Medicine, Gynecology, Pharmacotherapy +9

Long acting progestogens versus combined oral contraceptive pill for preventing recurrence of endometriosis related pain: the PRE-EMPT pragmatic, parallel group, open label, randomised controlled trial

Kevin Cooper, Jane Daniels, Andrew W. Horne et al. · BMJ · 2024 · 29 citations · Full text

Medicine, Gynecology, Obstetrics +17